Climb Bio (CLYM) Shares Issued (2020 - 2026)
Climb Bio (CLYM) posted Shares Issued of $8.5 million for Q1 2026, up 31.95% on a QoQ basis from $6.4 million in Q4 2025, and up 52.49% year-over-year from $5.6 million in Q1 2025.
Climb Bio (CLYM) Shares Issued (2020 - 2026) Analysis & Trends
Climb Bio's Shares Issued history runs 7 years deep, the most recent figure standing at $8.5 million for Q1 2026.
- Quarterly Shares Issued rose 52.49% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 52.49% YoY) and the FY2025 annual result came in at $6.4 million, up 128.12% from the prior year.
- Shares Issued was $8.5 million for Q1 2026 at Climb Bio, up from $6.4 million in the prior quarter.
- Across five years, Shares Issued topped out at $8.5 million in Q1 2026 and bottomed at $971646.0 in Q3 2024.
- A 5-year average of $4.6 million and a median of $4.5 million in 2022 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued jumped 2388.79% — and 2024, when it tumbled 80.13%.
- Climb Bio's Shares Issued stood at $6.0 million in 2022, then retreated by 23.41% to $4.6 million in 2023, then sank by 38.56% to $2.8 million in 2024, then surged by 128.12% to $6.4 million in 2025, then surged by 31.95% to $8.5 million in 2026.
- Business Quant data shows CLYM's Shares Issued at $8.5 million in Q1 2026, $6.4 million in Q4 2025, and $5.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 8.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.48 Mn |
| Mar 31, 2026 | 8.48 Mn |
| Dec 31, 2025 | 6.43 Mn |
| Dec 31, 2025 | 6.43 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 971,646.00 |
| Sep 30, 2024 | 971,646.00 |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Sep 30, 2023 | 4.89 Mn |